In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodies.

about

Enhanced pseudotyping efficiency of HIV-1 lentiviral vectors by a rabies/vesicular stomatitis virus chimeric envelope glycoprotein.Challenges in monoclonal antibody-based therapies.

P2860

Q34214473-DD2353DD-ADDA-4FFE-8515-B413EFFF5583 Q37398725-8D0BFA2B-C326-4AC8-9E34-7414421040B2

P2860

In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodies.

Item

http://www.wikidata.org/entity/Q40445773

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

In vivo evaluation of an EIAV ...... ery of therapeutic antibodies.

@en

type

Item

label

In vivo evaluation of an EIAV ...... ery of therapeutic antibodies.

@en

prefLabel

In vivo evaluation of an EIAV ...... ery of therapeutic antibodies.

@en

P1476

In vivo evaluation of an EIAV ...... ery of therapeutic antibodies.

@en

P2093

Carroll MW

http://www.w3.org/2001/XMLSchema#string

Ferris N

http://www.w3.org/2001/XMLSchema#string

Lamikanra A

http://www.w3.org/2001/XMLSchema#string

Mitrophanous KA

http://www.w3.org/2001/XMLSchema#string

Myers KA

http://www.w3.org/2001/XMLSchema#string

P2860

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

Immune responses to adenovirus and adeno-associated virus in humans.

The expression of 5T4 antigen in colorectal and gastric carcinoma

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression

EIAV, CAEV and other lentivirus vector systems.

Lentiviral vectors for gene delivery into cells.

Immunohistological distribution of 5T4 antigen in normal and malignant tissues

The glycoprotein G of rhabdoviruses.

Optimized lentiviral vector production and purification procedure prevents immune response after transduction of mouse brain.

Targeting immune effector molecules to human tumor cells through genetic delivery of 5T4-specific scFv fusion proteins.

P2888

sj.gt.3302484

P304

988-998

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.GT.3302484

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7961576

http://www.w3.org/2001/XMLSchema#string

P6179

1023038022

http://www.w3.org/2001/XMLSchema#string

P698

15772687

http://www.w3.org/2001/XMLSchema#string

In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodies.

about

P2860

P2860

In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698